Association of first-trimester low PAPP-A levels with preterm birth

Prenatal Diagnosis

Volumn 30, Issue 4, 2010, Pages 309-313

  Goetzinger, Katherine R ^a   Cahill, Alison G ^a   Macones, George A ^a   Odibo, Anthony O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

First trimester screening; Free hCG; Nuchal translucency; PAPP A; Preterm birth

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ANTEPARTUM HEMORRHAGE; AREA UNDER THE CURVE; BODY MASS; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; EXPOSURE; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; SMOKING;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; RETROSPECTIVE STUDIES;

NICOTIANA TABACUM;

EID: 77950662608     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2452     Document Type: Conference Paper

References (13)

1. Barrett SL, Bower C, Hadlow NC. 2008. Use of combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 28: 28-35.
2. Dugoff L, Hobbins JC, Malone FD, et al. 2004. First trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial). Am J Obstet Gynecol 191: 1446-1451.
3. Fox H. 1970. Effect of hypoxia on trophoblast in organ culture: a morphologic and autoradiographic study. Am J Obstet Gyneol 107: 1058-1064.
4. Krantz D, Goetzl L, Simpson JL, et al. 2004. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 191: 1452-1458.
5. Lawrence JB, Oxvig C, Overgaard MT, et al. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein A. Proc Natl Acad Sci 96: 3149-3153.
6. Ong CYT, Liao AW, Spencer K, et al. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107: 1265-1270.
7. Pihl K, Sorensen TL, Norgaard-Pedersen B, et al. 2008. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women. Prenat Diagn 28: 247-253.
8. She B, Chen S, Lee F, et al. 2007. Low maternal levels of pregnancy-associated plasma protein-A during the first trimester are associated with subsequent preterm delivery with preterm premature rupture of membranes. Taiwan J Obstet Gynecol 46: 242-247.
9. Smith GCS, Stenhouse EJ, Crossley JA, et al. 2002. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87: 1762-1767.
10. Spencer K, Cowans NJ, Molina F, et al. 2008. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 31: 147-152.
11. Steer P. 2005. The epidemiology of preterm labour. BJOG 112(Suppl 1): 1-3.
12. Tul N, Pusenjak S, Osredkar J, et al. 2003. Predicting complications of pregnancy with first-trimester maternal serum free-β hCG, PAPPA and inhibin-A. Prenat Diagn 23: 990-996.
13. Waller DK, Lustig LS, Smith AH, Hook EB. 1993. Alpha-fetoprotein: a biomarker for pregnancy outcome. Epidemiology 4: 471-476.